General Information of the Compound
| Compound ID |
CP0476014
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-2-[(7-methyl-2H-triazolo[4,5-d]pyrimidin-5-yl)amino]-4-[4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H43N11O3
|
||||||||||||||||||
| Molecular Weight |
629.77
|
||||||||||||||||||
| Canonical SMILES |
Cc1nc(N[C@@H](CC(=O)N2CCC(CC2)N2Cc3ccccc3NC2=O)C(=O)N2CCC(CC2)N2CCCCC2)nc2nn[nH]c12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H43N11O3/c1-21-28-29(38-39-37-28)36-31(33-21)34-26(30(45)42-17-9-23(10-18-42)40-13-5-2-6-14-40)19-27(44)41-15-11-24(12-16-41)43-20-22-7-3-4-8-25(22)35-32(43)46/h3-4,7-8,23-24,26H,2,5-6,9-20H2,1H3,(H,35,46)(H2,33,34,36,37,38,39)/t26-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MBFCRDYWDVDSTF-SANMLTNESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound